On-demand Webinar
Pioneering the obesity center of excellence
About the webinar
Nearly 50% of Americans are on track to have obesity by 2030. Organizations increasingly recognize the need for innovative and effective treatment options to both help manage the disease and control the associated costs.
Curious how an obesity center of excellence could help the people in your organization?
Dr. Fatima Cody Stanford, Associate Professor of Medicine at Harvard Medical School, and Dr. Richard Frank, Vida’s Chief Medical Officer, discuss implementing a virtual obesity center of excellence to meet this disease head-on.
Watch the replay to learn:
- Why addressing the multi-factorial nature of obesity needs a multi-disciplinary care team
- Dr. Stanford’s perspective on the role medications can play in treatment
- How an obesity center of excellence with trained obesity medicine providers can deliver the gold standard in care
Resources
-
The cost of discontinued care: Why GLP-1 coverage fails without clinical continuity
If your organization’s cardiometabolic health strategy begins and ends with GLP-1 coverage, you don’t really have a strategy. You have a pharmacy decision masquerading as population health.
-
What Employers need to know before dropping GLP-1 coverage
Now more than ever employers and plan sponsors are considering altering or removing GLP-1 coverage, but short-term cost cuts can quickly become long term expenses. This guide can help you make a strategic informed decision whether you decide keep GLP-1s on formulary or not.
-
Clinicians or Technology? What we should be asking instead.
This crisis in accessibility has laid the foundation for an unproductive debate: should we rely more heavily on clinicians, or tech and AI? But that’s the wrong argument. The real question is whether care models deliver measurable, durable outcomes, beyond who or what is providing that care.